Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancer
Not Applicable
Recruiting
- Conditions
- Head and neck cancer
- Registration Number
- JPRN-UMIN000042276
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 475
Inclusion Criteria
Not provided
Exclusion Criteria
1) Have a history or complication of other cancers 2) Judged as lacking consent due to dementia or mental illness 3)Patients who have decided inappropriate to include in this study by the investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers in JPRN-UMIN000042276 correlate with recurrence risk in head and neck squamous cell carcinoma?
How do PD-L1 expression and HPV status influence therapeutic outcomes in the National Cancer Center Hospital East head and neck cancer observational study?
Which circulating tumor DNA markers predict response to immunotherapy in JPRN-UMIN000042276 head and neck cancer patients?
What adverse event profiles are associated with biomarker-guided treatment strategies in head and neck cancer observational trials?
How does JPRN-UMIN000042276 compare to other studies on EGFR mutation status and therapeutic resistance in head and neck malignancies?